Literature DB >> 21768699

Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.

Hong-Han Wang1, Xing-Wei Wang, Can-E Tang.   

Abstract

PURPOSE: To investigate osteopontin (OPN) expression in human nasopharyngeal carcinoma (NPC) and evaluate its clinical significance in the disease.
MATERIALS AND METHODS: The expression of OPN mRNA in 44 frozen NPC tissue and 15 normal nasopharyngeal epithelium tissue (NNET) samples was examined by semi-quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). OPN protein expression in 67 paraffin-embedded NPC tissue and 21 NNET samples was detected by immunohistochemistry (IHC). In addition, OPN expression was investigated in 12 paired NPC and para-carcinoma tissue (PCT) samples by western blotting (WB). The association between the expression of OPN and the clinicopathologic parameters of NPC was evaluated.
RESULTS: Three different methods all showed that the expression of OPN mRNA or protein in NPC was significantly higher than in NNET or PCT (P = 0.000, 0.001, 0.000, respectively). After an examination by IHC, 88.1% (59/67) of NPC samples showed strong or moderate positive OPN staining and 28.6% (6/21) of NNET samples displayed a weak positive OPN staining. The staining of OPN in tumor cells was mainly localized to the cytoplasm. OPN expression in NPC was not related to patient age or sex (P > 0.05), but was significantly related to tumor size, regional lymph nodal metastasis, and NPC clinical stages (P < 0.05).
CONCLUSIONS: Our study demonstrated that OPN mRNA and protein overexpression in NPC may be important in the pathogenesis of the disease. It was strongly related to T stage, N stage and clinical stages of NPC, suggesting that OPN may be involved in NPC metastasis and progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768699     DOI: 10.4103/0973-1482.82926

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  8 in total

Review 1.  Role of osteopontin in the pathophysiology of cancer.

Authors:  Lalita A Shevde; Rajeev S Samant
Journal:  Matrix Biol       Date:  2014-03-19       Impact factor: 11.583

2.  Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.

Authors:  Haimei Qin; Rong Wang; Guijiang Wei; Huaifei Wang; Guogang Pan; Rentong Hu; Yesheng Wei; Renguang Tang; Junli Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-06       Impact factor: 2.503

Review 3.  OPN -Revisited.

Authors:  Vijayanirmala Subraman; Muthukumar Thiyagarajan; N Malathi; Sharada T Rajan
Journal:  J Clin Diagn Res       Date:  2015-06-01

4.  Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.

Authors:  Jun-li Wang; Le-gen Nong; Yu-jin Tang; Ye-sheng Wei; Feng-lian Yang; Chun-fang Wang
Journal:  Med Oncol       Date:  2014-06-10       Impact factor: 3.064

5.  Expression of Osteopontin in Oral Squamous Cell Carcinoma and its Surgical Margins-An Immunohistochemical Study.

Authors:  Vijaya Nirmala Subramani; Malathi Narasimhan; Muthukumar Thiyagarajan; Balu David Munuswamy; Logeswari Jayamani
Journal:  J Clin Diagn Res       Date:  2015-11-01

6.  Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.

Authors:  Antje Hahnel; Henri Wichmann; Thomas Greither; Matthias Kappler; Peter Würl; Matthias Kotzsch; Helge Taubert; Dirk Vordermark; Matthias Bache
Journal:  BMC Cancer       Date:  2012-04-02       Impact factor: 4.430

7.  Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study.

Authors:  Christoph Aderhold; Guido Manuel Grobschmidt; Alexander Sauter; Anne Faber; Karl Hörmann; Johannes David Schultz
Journal:  Oncol Lett       Date:  2014-07-04       Impact factor: 2.967

8.  OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC.

Authors:  Yanzhang Hao; Jianwei Liu; Ping Wang; Feng Wang; Zeshun Yu; Mianli Li; Shaoshui Chen; Fangling Ning
Journal:  Int J Genomics       Date:  2014-08-05       Impact factor: 2.326

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.